More on McDermott (MDR): Q4 comes up shy on a per share basis but beats on revenue as total sales jumped 22% AH. Net profit grew amid strong revenue growth, led by its Asia-Pacific business. Backlog was $5.1B, up sharply from $3.9B a year earlier, but down from $5.3B at the end of Q3. The company lowers sales estimates for FY13, now expecting total revenue of about $3B. Analysts are looking for $ 3.12B. Shares -5.6% AH.